Handa Pharmaceuticals, Inc.
TPEX:6620 Rapporto sulle azioni
Handa Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 6/6 Handa Pharmaceuticals ha un patrimonio netto totale di NT$2.9B e un debito totale di NT$0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente NT$3.1B e NT$244.7M. L'EBIT di Handa Pharmaceuticals è NT$525.4M rendendo il suo rapporto di copertura degli interessi -11.5. Ha liquidità e investimenti a breve termine pari a NT$2.5B.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
Indice di copertura degli interessi -11.5x Contanti NT$2.53b Patrimonio netto NT$2.90b Totale passività NT$244.70m Totale attività NT$3.15b
Aggiornamenti recenti sulla salute finanziaria
Mostra tutti gli aggiornamenti
New minor risk - Dividend sustainability Oct 25
Second quarter 2024 earnings released: EPS: NT$0.73 (vs NT$1.90 in 2Q 2023) Aug 17
Investor sentiment deteriorates as stock falls 15% Jul 29
Investor sentiment deteriorates as stock falls 17% May 30
First quarter 2024 earnings released: EPS: NT$0.83 (vs NT$1.90 in 1Q 2023) May 19
Investor sentiment improves as stock rises 16% May 13
New minor risk - Share price stability Apr 20
Investor sentiment deteriorates as stock falls 15% Apr 17
Handa Pharmaceuticals, Inc., Annual General Meeting, Jun 20, 2024 Apr 03
Full year 2023 earnings released: EPS: NT$5.41 (vs NT$0.32 loss in FY 2022) Apr 03
New minor risk - Share price stability Jan 30
Third quarter 2023 earnings released: EPS: NT$1.07 (vs NT$0.18 in 3Q 2022) Dec 28
New minor risk - Share price stability Nov 17
New minor risk - Shareholder dilution Sep 10
Full year 2022 earnings released: NT$0.32 loss per share (vs NT$2.10 loss in FY 2021) Apr 22
Less than half of directors are independent Nov 16
First half 2022 earnings released: NT$0.71 loss per share (vs NT$1.01 loss in 1H 2021) Aug 17
Full year 2021 earnings released: NT$2.10 loss per share (vs NT$2.44 loss in FY 2020) Apr 30
Less than half of directors are independent Apr 27
First half 2021 earnings released: NT$1.01 loss per share (vs NT$1.26 loss in 1H 2020) Aug 18
Handa Pharmaceuticals, Inc., Annual General Meeting, Jun 08, 2021 Mar 20
New 90-day high: NT$30.70 Feb 25
Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years. Feb 24
New 90-day high: NT$28.15 Jan 04
We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth Dec 29
New 90-day high: NT$27.15 Nov 07
New 90-day low: NT$22.05 Sep 24
First half earnings released Aug 13
New 90-day low - NT$26.95 Aug 06
Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( NT$2.8B ) di 6620 superano le sue passività a breve termine ( NT$156.0M ).
Passività a lungo termine: Le attività a breve termine di 6620 ( NT$2.8B ) superano le sue passività a lungo termine ( NT$88.7M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 6620 è esente da debiti.
Riduzione del debito: 6620 non aveva debiti 5 anni fa.
Copertura del debito: 6620 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo .
Copertura degli interessi: 6620 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
